Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
616.90
Change Change %
-20.20 -3.17%

Updated:14 Jun, 2019, 15:59 PM IST

BSE
616.30
Change Change %
-20.35 -3.20%

Updated:14 Jun, 2019, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Citi
N/A
19-03-2015 Buy 1262.10 1945.00
N/A
Closed Custom
19-03-2016

Citi maintains buy on Aurobindo Pharma

Aurobindo Pharma is the top mid-cap pharma pick. Expect strong earnings per share growth for FY14-17. Company has been improving its balance sheet to drive re-rating.

Top